NLRP3 and inflammatory bowel disease: In addition to their role in IBD, the therapeutic effects of MSCs and their exosomes in the regulation of NLRP3 inflammasome activation have been extensively studied in inflammatory diseases of the central nervous system (278) and myocarditis (270).